Company Overview of Applied Immune Technologies Ltd.
Applied Immune Technologies Ltd. engages in the development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications in pathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel. As of January 27, 2016, Applied Immune Technologies Ltd. operates as a subsidiary of Adicet Bio, Inc.
Gutwirth Industrial Park
Founded in 2006
972 4 8122216
972 4 8122294
Key Executives for Applied Immune Technologies Ltd.
Applied Immune Technologies Ltd. Key Developments
Similar Private Companies By Industry
|Accelerated Evolution Biotechnologies Ltd||Middle East/Africa|
|Adante Ltd.||Middle East/Africa|
|Advanced Biotechnology Ltd.||Middle East/Africa|
|Advanced Medical Analysis (AMA) Ltd.||Middle East/Africa|
|Advanced Neuroprotective System Ltd.||Middle East/Africa|
Recent Private Companies Transactions
January 27, 2016
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Applied Immune Technologies Ltd., please visit www.tcrl.co.il. Company data is provided by Capital IQ. Please use this form to report any data issues.